- Created on Saturday, 17 March 2012 20:38
Automatically Generated - Will be deleted after first publication of article.
New Diet drug may have heart-risk studies: FDA
New anti-obesity drugs may need to undergo studies to evaluate potential risks hearts before they are approved for sale in the United States, according to a Food and Drug Administration evaluation.
Outside experts advising the FDA soon by three California-based applications for the first weight loss pills available in the U.S. market will be launched in 13 years, told Bloomberg News.
Are the experts, whether considered "obese without a theoretical risk, or a signal for" potential damage to the heart "should be required to be excluded," a measure of cardiovascular risk before approval, said the FDA staff report.